---

1.媒體來源:

Bloomberg News
彭博社

2.記者署名:
Arys Aditya, Emma O'Brien, Dong Lyu, Claire Che, Tassia Sipahutar, and Soraya
Permatasari


3.完整新聞標題:

彭博：中國科興疫苗在現實世界的研究中被發現非常有效
China Sinovac Shot Seen Highly Effective in Real World Study


4.完整新聞內文:

Sinovac Biotech Ltd.’s vaccine is wiping out Covid-19 among health workers
in Indonesia, an encouraging sign for the dozens of developing countries
reliant on the controversial Chinese shot, which performed far worse than
western vaccines in clinical trials.


Indonesia tracked 128,290 health workers in capital city Jakarta from January
to March and found that the vaccine protected 98% of them from death and 96%
from hospitalization as soon as seven days after the second dose, Pandji
Dhewantara, a Health Ministry official who oversaw the study, said in a
Wednesday press conference.



Dhewantara also said that 94% of the workers had been protected against
symptomatic infection -- an extraordinary result that goes beyond what was
measured in the shot’s numerous clinical trials.




Health Minister Budi Gunadi
Sadikin eaErlier revealed a smaller version of the study involving 25,374
people in a Tuesday interview with Bloomberg that had the same effectiveness
data for hospitalization and infection. Protection against death was 100% in
the smaller group.




Sadikin表示，「我們看到醫護人員的住院和死亡人數急劇下降。」尚不清楚科興疫苗在
印尼抵禦了何種病毒株，但該國尚未爆出由變種病毒引發的任何重大疫情。


“We see a very, very drastic drop,” in hospitalizations and deaths among
medical workers, Sadikin said. It’s not known what strain of the coronavirus
Sinovac’s shot worked against in Indonesia, but the country has not flagged
any major outbreaks driven by variants of concern.

科興生物北京發言人表示，在取得更多詳細信息之前，公司對印尼這項研究不作評論。

科興執行長尹衛東周二接受彭博另一次專訪時表示，有越來越多證據表明科興新冠疫苗在
現實世界中使用時表現得更好。



相比之下，智利在為1,900萬人口中逾三分之一接種疫苗後出現了疫情再度爆發。



他說，由於病毒的變異，疫苗的保護作用可能因地而異，但科興生物的疫苗似乎可以很好
地抵抗變異毒株。



以色列的一項研究顯示，由BioNTech SE和輝瑞開發的mRNA疫苗在防止病毒傳播方面有效
率超過90%。

奧克蘭大學的疫苗學家Helen Petousis-Harris表示，與臨床試驗相比，現實世界中疫苗
控制疾病的能力可能更高。




5.完整新聞連結 (或短網址):


https://www.bloomberg.com/news/articl...-effective-in-real-world-study

缩网址： https://reurl.cc/WElAy9



6.備註:
※ 一個人三天只能張貼一則新聞，被刪或自刪也算額度內，超貼者水桶，請注意
※ 備註請勿張貼三日內新聞(包含連結、標題等)


--
--
※ 發信站: 批踢踢實業坊(ptt.cc), 來自: 69.126.22.238 (美國)
※ 文章代碼(AID): #1WdeGQTu (Gossiping)
※ 文章網址: https://www.ptt.cc/bbs/Gossiping/M.1621001242.A.778.html